NAV05/09/2024 Chg.-0.9470 Type de rendement Focus sur l'investissement Société de fonds
111.4610EUR -0.84% paying dividend Equity Worldwide SEB IM 

Stratégie d'investissement

The fund aims to increase the value of your investment over time and to outperform its benchmark. The fund is actively managed and invests in stocks globally, primarily in the biotech sector. Investment decisions are based on in-depth (fundamental) analysis. The focus is on companies' business models, earning capacity, management and market positions. The return is determined by how much the fund's holdings increase or decrease in value during your holding period.
 

Objectif d'investissement

The fund aims to increase the value of your investment over time and to outperform its benchmark.
 

Opérations

Type de rendement: paying dividend
Fonds Catégorie: Equity
Région de placement: Worldwide
Branche: Sector Biotechnology
Benchmark: Nasdaq Biotechnology Index
Début de l'exercice: 01/01
Dernière distribution: 23/05/2024
Banque dépositaire: Skandinaviska Enskilda Banken AB, Lux
Domicile: Luxembourg
Permission de distribution: Germany, Czech Republic
Gestionnaire du fonds: Angelica Fatouros
Actif net: 141.2 Mio.  EUR
Date de lancement: 16/10/2000
Focus de l'investissement: -

Conditions

Surtaxe d'émission: 0.00%
Frais d'administration max.: 1.50%
Investissement minimum: - EUR
Deposit fees: -
Frais de rachat: 0.00%
Prospectus simplifié: Télécharger (Version imprimée)
 

Société de fonds

Société de fonds: SEB IM
Adresse: Stephanstraße 14 - 16, 60313, Frankfurt am Main
Pays: Germany
Internet: seb.de/asset-management
 

Actifs

Stocks
 
97.31%
Cash
 
2.69%

Pays

United States of America
 
77.41%
United Kingdom
 
6.78%
Sweden
 
2.91%
Denmark
 
2.70%
Cash
 
2.69%
Netherlands
 
2.65%
Ireland
 
1.50%
Bermuda
 
1.36%
Canada
 
1.10%
Cayman Islands
 
0.89%
Autres
 
0.01%

Branches

Pharma/Biotechnology
 
92.77%
Healthcare services
 
3.76%
Cash
 
2.69%
Healthcare appliances
 
0.77%
Autres
 
0.01%